InvestorsHub Logo
Followers 8
Posts 400
Boards Moderated 0
Alias Born 08/14/2017

Re: None

Monday, 11/06/2017 10:59:25 AM

Monday, November 06, 2017 10:59:25 AM

Post# of 19466

One of the most diverse vaccine pipelines in the world 11 vaccines and counting single shot HIV Vaccine and Zika to commence in Humans soon and phase 2B for GOV-B11-Claude B, Cancer Immunotherapy vaccines. Top Universities and vaccine scientist including Monath, Frashad, Plotkin, and Graham and Harriet L Robinson one of the leading researchers in HIV vaccines development. This company is extremely undervalued at 3.7 Million Yes thats under a 4 Million Market cap and and about 65 Million Shares 1/3 of those shares are owned by Inst and Insiders and private placements. GOVX should see a .25-.50 Price and then a climb to dollars in 2018. I believe a $15.00-$25.00 price target by 2020
https://www.geovax.com/clinical-pipeline.html
Less
Aids Vaccine Research - GeoVax, Inc.
Aids Vaccine Research - GeoVax, Inc.
www.geovax.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News